Skip to content

Latest News & Updates

Panthera in the News
Abstract purple gradient background

UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites

Abstract purple gradient background

Speeding up trial enrolment can save billions

Abstract purple gradient background

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

A group of men and women in corporate team

Panthera partnership with Preston North End Community Trust

Laboratory technician preparing samples

Valneva vaccine clinical trial, phase 3 results

Dr Amir Afzul and a patient

Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine to volunteers in COVID prevention study

Purple Panthera branded background graphic

Clinical trial specialist Panthera Biopartners has appointed corporate financier Christopher Steed as a non-executive director to continue its expansion both in the UK and overseas

Man speaking in meeting room

Panthera adapts for COVID-19 virus – Letter from Stuart Young, CEO

Ready to take part?

Join this trial and help shape future treatments today

Register for trials